Mark Papania

2.0k total citations
40 papers, 1.2k citations indexed

About

Mark Papania is a scholar working on Epidemiology, Health and Immunology. According to data from OpenAlex, Mark Papania has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 22 papers in Health and 14 papers in Immunology. Recurrent topics in Mark Papania's work include Virology and Viral Diseases (30 papers), Vaccine Coverage and Hesitancy (22 papers) and Immune responses and vaccinations (11 papers). Mark Papania is often cited by papers focused on Virology and Viral Diseases (30 papers), Vaccine Coverage and Hesitancy (22 papers) and Immune responses and vaccinations (11 papers). Mark Papania collaborates with scholars based in United States, Switzerland and Australia. Mark Papania's co-authors include Walter A. Orenstein, Paul A. Rota, William J. Bellini, Susan B. Redd, Jennifer S. Rota, Peter M. Strebel, Susan E. Reef, Jane F. Seward, Alan R. Hinman and Stephen L. Cochi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and PEDIATRICS.

In The Last Decade

Mark Papania

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Papania United States 20 895 567 328 295 128 40 1.2k
Heidi Theeten Belgium 21 920 1.0× 412 0.7× 272 0.8× 159 0.5× 88 0.7× 73 1.3k
Dominick Iacuzio United States 8 1.3k 1.4× 151 0.3× 419 1.3× 254 0.9× 54 0.4× 10 1.5k
Ken Zangwill United States 7 1.4k 1.6× 145 0.3× 432 1.3× 358 1.2× 51 0.4× 8 1.6k
Karen Kotloff United States 7 1.5k 1.7× 156 0.3× 502 1.5× 403 1.4× 52 0.4× 8 1.7k
Leonard R. Friedland United States 24 646 0.7× 257 0.5× 459 1.4× 201 0.7× 35 0.3× 54 1.6k
Piero Luigi Lai Italy 20 712 0.8× 196 0.3× 319 1.0× 120 0.4× 59 0.5× 65 1.2k
Kempapura Murthy United States 22 1.4k 1.6× 213 0.4× 359 1.1× 224 0.8× 168 1.3× 49 1.6k
José Luis Valdespino‐Gómez Mexico 16 720 0.8× 158 0.3× 544 1.7× 116 0.4× 31 0.2× 30 961
David Featherstone Switzerland 18 771 0.9× 314 0.6× 406 1.2× 202 0.7× 72 0.6× 28 1.0k
Sandra W. Roush United States 7 518 0.6× 334 0.6× 263 0.8× 71 0.2× 47 0.4× 13 849

Countries citing papers authored by Mark Papania

Since Specialization
Citations

This map shows the geographic impact of Mark Papania's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Papania with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Papania more than expected).

Fields of papers citing papers by Mark Papania

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Papania. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Papania. The network helps show where Mark Papania may publish in the future.

Co-authorship network of co-authors of Mark Papania

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Papania. A scholar is included among the top collaborators of Mark Papania based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Papania. Mark Papania is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fischer, Leah S., et al.. (2024). Estimates of Potential Demand for Measles and Rubella Microarray Patches. Vaccines. 12(9). 1083–1083. 1 indexed citations
2.
Hampton, Lee M., Paul A. Rota, Mick N. Mulders, et al.. (2024). Use of Measles and Rubella Rapid Diagnostic Tests to Improve Case Detection and Targeting of Vaccinations. Vaccines. 12(8). 823–823. 2 indexed citations
3.
Malvolti, Stefano, Carsten Mantel, Robin Biellik, et al.. (2023). Estimating the future global dose demand for measles–rubella microarray patches. Frontiers in Public Health. 10. 1037157–1037157. 9 indexed citations
4.
Sbarra, Alyssa N., Mark Jit, Jonathan F Mosser, et al.. (2023). Population-Level Risk Factors Related to Measles Case Fatality: A Conceptual Framework Based on Expert Consultation and Literature Review. Vaccines. 11(8). 1389–1389. 2 indexed citations
5.
Grant, Gavin B., Rania A. Tohme, Cynthia Hatcher, et al.. (2023). Lessons learnt from the applying the Centers for Disease Control and Prevention (CDC) evaluation framework to the measles incident management system response, USA, 2020–2021. BMJ Global Health. 8(3). e011861–e011861. 2 indexed citations
6.
Dixon, Meredith G., Milagritos D. Tapia, Kathleen Wannemuehler, et al.. (2022). Measles susceptibility in maternal-infant dyads—Bamako, Mali. Vaccine. 40(9). 1316–1322. 6 indexed citations
7.
Luczo, Jasmina M., Tatiana Bousse, Scott K. Johnson, et al.. (2021). Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets. npj Vaccines. 6(1). 59–59. 12 indexed citations
8.
Pavlicek, Rebecca L., Simon O. Owino, Kaori Sakamoto, et al.. (2018). Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs. Tuberculosis. 113. 179–188. 5 indexed citations
9.
Laube, Beth L., et al.. (2015). Intranasal Deposition of Accuspray™ Aerosol in Anatomically Correct Models of 2-, 5-, and 12-Year-Old Children. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(5). 320–333. 17 indexed citations
10.
Jarrahian, Courtney, et al.. (2015). Clinical performance and safety of adapters for intradermal delivery with conventional and autodisable syringes. Vaccine. 33(37). 4705–4711. 6 indexed citations
11.
Coughlin, Melissa M., Marcus L. Collins, Courtney Jarrahian, et al.. (2015). Effect of jet injection on infectivity of measles, mumps, and rubella vaccine in a bench model. Vaccine. 33(36). 4540–4547. 3 indexed citations
12.
Papania, Mark, Darin A. Knaus, Paula Brooks, et al.. (2011). Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose. Vaccine. 30(19). 3026–3033. 17 indexed citations
13.
Brooks, Paula, Scott K. Johnson, S. Mark Tompkins, et al.. (2011). Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice. Vaccine. 29(14). 2568–2575. 14 indexed citations
14.
Pasetti, Marcela F., Aldo Arturo Reséndiz‐Albor, Karina Ramírez, et al.. (2007). Heterologous Prime–Boost Strategy to Immunize Very Young Infants against Measles: Pre-clinical Studies in Rhesus Macaques. Clinical Pharmacology & Therapeutics. 82(6). 672–685. 27 indexed citations
15.
Swart, Rik L. de, Thijs Kuiken, Mark Papania, et al.. (2006). Aerosol measles vaccination in macaques: Preclinical studies of immune responses and safety. Vaccine. 24(40-41). 6424–6436. 29 indexed citations
16.
Berraho, A., et al.. (2005). Congenital rubella syndrome burden in Morocco: a rapid retrospective assessment. The Lancet. 365(9454). 135–141. 29 indexed citations
17.
Hyde, Terri B., Gustavo H. Dayan, Robin Nandy, et al.. (2005). Measles outbreak in the Republic of the Marshall Islands, 2003. International Journal of Epidemiology. 35(2). 299–306. 29 indexed citations
18.
Papania, Mark & Peter M. Strebel. (2005). Measles surveillance: the importance of finding the tip of the iceberg. The Lancet. 365(9454). 100–101. 10 indexed citations
19.
Orenstein, Walter A., Alan R. Hinman, & Mark Papania. (2004). Evolution of Measles Elimination Strategies in the United States. The Journal of Infectious Diseases. 189(Supplement_1). S17–S22. 55 indexed citations
20.
Orenstein, Walter A., Peter M. Strebel, Mark Papania, et al.. (2000). Measles eradication: is it in our future?. American Journal of Public Health. 90(10). 1521–1525. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heidi Theeten Breakdown of academic impact, for papers by Dominick Iacuzio Breakdown of academic impact, for papers by Ken Zangwill Breakdown of academic impact, for papers by Karen Kotloff Breakdown of academic impact, for papers by Leonard R. Friedland Breakdown of academic impact, for papers by Piero Luigi Lai Breakdown of academic impact, for papers by Kempapura Murthy Breakdown of academic impact, for papers by José Luis Valdespino‐Gómez Breakdown of academic impact, for papers by David Featherstone Breakdown of academic impact, for papers by Sandra W. Roush
Rankless by CCL
2026